Cholinergic hypofunction in MeCP2-308 mice: Beneficial neurobehavioural effects of neonatal choline supplementation

Behavioural Brain Research

Volumn 221, Issue 2, 2011, Pages 623-629

  Ricceri, Laura ^a   De Filippis, Bianca ^a   Fuso, Andrea ^b   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Behavioural phenotyping; Cholinergic system; Neurotrophines; Nutritional factors; Rett syndrome; Scopolamine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINE; CHOLINE ACETYLTRANSFERASE; MESSENGER RNA; NERVE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEMIZYGOSITY; HETEROZYGOSITY; HIPPOCAMPUS; LOCOMOTION; MALE; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; RETT SYNDROME; STRIATE CORTEX; WEIGHT GAIN;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; CHOLINE; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; CORPUS STRIATUM; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, MUTANT STRAINS; MOTOR ACTIVITY; NERVE GROWTH FACTOR; RETT SYNDROME; SCOPOLAMINE;

EID: 79955731338     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.03.051     Document Type: Article

References (73)

1. Hagberg B. Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 2002, 8:61-65.
2. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188.
3. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007, 56:422-437.
4. Chadwick L.H., Wade P.A. MeCP2 in Rett syndrome: transcriptional repressor or chromatin architectural protein?. Curr Opin Genet Dev 2007, 17:121-125.
5. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
6. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001, 27:327-331.
7. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001, 27:322-326.
8. De Filippis B., Ricceri L., Laviola G. Early postnatal behavioral changes in the Mecp2-308 truncation mouse model of Rett syndrome. Genes Brain Behav 2010, 9:213-223.
9. McGill B.E., Bundle S.F., Yaylaoglu M.B., Carson J.P., Thaller C., Zoghbi H.Y. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 2006, 103:18267-18272.
10. Moretti P., Bouwknecht J.A., Teague R., Paylor R., Zoghbi H.Y. Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum Mol Genet 2005, 14:205-220.
11. Saywell V., Viola A., Confort-Gouny S., Le Fur Y., Villard L., Cozzone P.J. Brain magnetic resonance study of Mecp2 deletion effects on anatomy and metabolism. Biochem Biophys Res Commun 2006, 340:776-783.
12. Ward B.C., Kolodny N.H., Nag N., Berger-Sweeney J.E. Neurochemical changes in a mouse model of Rett syndrome: changes over time and in response to perinatal choline nutritional supplementation. J Neurochem 2009, 108:361-371.
13. Horska A., Naidu S., Herskovits E.H., Wang P.Y., Kaufmann W.E., Barker P.B. Quantitative 1H MR spectroscopic imaging in early Rett syndrome. Neurology 2000, 54:715-722.
14. Naidu S., Kaufmann W.E., Abrams M.T., Pearlson G.D., Lanham D.C., Fredericksen K.A., et al. Neuroimaging studies in Rett syndrome. Brain Dev 2001, 23(Suppl. 1):S62-S71.
15. Hanefeld F., Christen H.J., Holzbach U., Kruse B., Frahm J., Hanicke W. Cerebral proton magnetic resonance spectroscopy in Rett syndrome. Neuropediatrics 1995, 26:126-127.
16. Gokcay A., Kitis O., Ekmekci O., Karasoy H., Sener R.N. Proton MR spectroscopy in Rett syndrome. Comput Med Imaging Graph 2002, 26:271-275.
17. Khong P.L., Lam C.W., Ooi C.G., Ko C.H., Wong V.C. Magnetic resonance spectroscopy and analysis of MECP2 in Rett syndrome. Pediatr Neurol 2002, 26:205-209.
18. Garner S.C., Mar M.H., Zeisel S.H. Choline distribution and metabolism in pregnant rats and fetuses are influenced by the choline content of the maternal diet. J Nutr 1995, 125:2851-2858.
19. Zeisel S.H., Niculescu M.D. Perinatal choline influences brain structure and function. Nutr Rev 2006, 64:197-203.
20. Guo-Ross S.X., Clark S., Montoya D.A., Jones K.H., Obernier J., Shetty A.K., et al. Prenatal choline supplementation protects against postnatal neurotoxicity. J Neurosci 2002, 22:RC195.
21. Meck W.H., Smith R.A., Williams C.L. Pre- and postnatal choline supplementation produces long-term facilitation of spatial memory. Dev Psychobiol 1988, 21:339-353.
22. Ricceri L., Berger-Sweeney J. Postnatal choline supplementation in preweanling mice: sexually dimorphic behavioral and neurochemical effects. Behav Neurosci 1998, 112:1387-1392.
23. Napoli I., Blusztajn J.K., Mellott T.J. Prenatal choline supplementation in rats increases the expression of IGF2 and its receptor IGF2R and enhances IGF2-induced acetylcholine release in hippocampus and frontal cortex. Brain Res 2008, 1237:124-135.
24. Sandstrom N.J., Loy R., Williams C.L. Prenatal choline supplementation increases NGF levels in the hippocampus and frontal cortex of young and adult rats. Brain Res 2002, 947:9-16.
25. Wong-Goodrich S.J., Mellott T.J., Glenn M.J., Blusztajn J.K., Williams C.L. Prenatal choline supplementation attenuates neuropathological response to status epilepticus in the adult rat hippocampus. Neurobiol Dis 2008, 30:255-269.
26. Ilcol Y.O., Ozbek R., Hamurtekin E., Ulus I.H. Choline status in newborns, infants, children, breast-feeding women, breast-fed infants and human breast milk. J Nutr Biochem 2005, 16:489-499.
27. Pinotti L., Baldi A., Politis I., Rebucci R., Sangalli L., Dell'Orto V. Rumen-protected choline administration to transition cows: effects on milk production and vitamin E status. J Vet Med A Physiol Pathol Clin Med 2003, 50:18-21.
28. Deuchler K.N., Piperova L.S., Erdman R.A. Milk choline secretion as an indirect indicator of postruminal choline supply. J Dairy Sci 1998, 81:238-242.
29. Holmes-McNary M.Q., Cheng W.L., Mar M.H., Fussell S., Zeisel S.H. Choline and choline esters in human and rat milk and in infant formulas. Am J Clin Nutr 1996, 64:572-576.
30. Rohlfs E.M., Garner S.C., Mar M.H., Zeisel S.H. Glycerophosphocholine and phosphocholine are the major choline metabolites in rat milk. J Nutr 1993, 123:1762-1768.
31. Meck W.H., Williams C.L. Metabolic imprinting of choline by its availability during gestation: implications for memory and attentional processing across the lifespan. Neurosci Biobehav Rev 2003, 27:385-399.
32. Nag N., Berger-Sweeney J.E. Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome. Neurobiol Dis 2007, 26:473-480.
33. Nag N., Mellott T.J., Berger-Sweeney J.E. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome. Brain Res 2008, 1237:101-109.
34. Nag N., Ward B., Berger-Sweeney J.E. Nutritional factors in a mouse model of Rett syndrome. Neurosci Biobehav Rev 2009, 33:586-592.
35. Wenk G.L., Hauss-Wegrzyniak B. Altered cholinergic function in the basal forebrain of girls with Rett syndrome. Neuropediatrics 1999, 30:125-129.
36. Chang Q., Khare G., Dani V., Nelson S., Jaenisch R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 2006, 49:341-348.
37. Zeev B.B., Bebbington A., Ho G., Leonard H., de Klerk N., Gak E., et al. The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome. Neurology 2009, 72:1242-1247.
38. Kondo M., Gray L.J., Pelka G.J., Christodoulou J., Tam P.P., Hannan A.J. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome - Mecp2 gene dosage effects and BDNF expression. Eur J Neurosci 2008, 27:3342-3350.
39. Ogier M., Wang H., Hong E., Wang Q., Greenberg M.E., Katz D.M. Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J Neurosci 2007, 27:10912-10917.
40. Hoffbuhr K.C., Moses L.M., Jerdonek M.A., Naidu S., Hoffman E.P. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Ment Retard Dev Disabil Res Rev 2002, 8:99-105.
41. Laviola G., Adriani W., Gaudino C., Marino R., Keller F. Paradoxical effects of prenatal acetylcholinesterase blockade on neuro-behavioral development and drug-induced stereotypies in reeler mutant mice. Psychopharmacology (Berlin) 2006, 187:331-344.
42. Alleva E., Bignami G. Development of mouse activity, stimulus reactivity, habituation, and response to amphetamine and scopolamine. Physiol Behav 1985, 34:519-523.
43. Yamaguchi Y., Higashi M., Kobayashi H. Effects of ginsenosides on maze performance and brain choline acetyltransferase activity in scopolamine-treated young rats and aged rats. Eur J Pharmacol 1997, 329:37-41.
44. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 1975, 24:407-409.
45. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
46. Zaheer A., Haas J.T., Reyes C., Mathur S.N., Yang B., Lim R. GMF-knockout mice are unable to induce brain-derived neurotrophic factor after exercise. Neurochem Res 2006, 31:579-584.
47. Fuso A., Nicolia V., Cavallaro R.A., Ricceri L., D'Anselmi F., Coluccia P., et al. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol Cell Neurosci 2008, 37:731-746.
48. De Filippis B., Ricceri L., Laviola G. Investigating Rett syndrome through genetic mouse models: pre-symptomatic clearly symptomatic phases and innovative therapeutic approaches. Mutant and transgenic tools in modeling brain disorders. Neuromethods 2010, 44:151-178. Humana Press Inc, Totowa, NJ.
49. Semba K., Fibiger H.C. Organization of central cholinergic systems. Prog Brain Res 1989, 79:37-63.
50. Stevens K.E., Adams C.E., Yonchek J., Hickel C., Danielson J., Kisley M.A. Permanent improvement in deficient sensory inhibition in DBA/2 mice with increased perinatal choline. Psychopharmacology (Berlin) 2008, 198:413-420.
51. Davison J.M., Mellott T.J., Kovacheva V.P., Blusztajn J.K. Gestational choline supply regulates methylation of histone H3, expression of histone methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA methylation of their genes in rat fetal liver and brain. J Biol Chem 2009, 284:1982-1989.
52. Jones J.P., Meck W.H., Williams C.L., Wilson W.A., Swartzwelder H.S. Choline availability to the developing rat fetus alters adult hippocampal long-term potentiation. Brain Res Dev Brain Res 1999, 118:159-167.
53. Blusztajn J.K. Choline a vital amine. Science 1998, 281:794-795.
54. Cermak J.M., Holler T., Jackson D.A., Blusztajn J.K. Prenatal availability of choline modifies development of the hippocampal cholinergic system. Faseb J 1998, 12:349-357.
55. Meck W.H., Smith R.A., Williams C.L. Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both. Behav Neurosci 1989, 103:1234-1241.
56. Yang Y., Liu Z., Cermak J.M., Tandon P., Sarkisian M.R., Stafstrom C.E., et al. Protective effects of prenatal choline supplementation on seizure-induced memory impairment. J Neurosci 2000, 20:RC109.
57. Johnston M.V., Rutkowski J.L., Wainer B.H., Long J.B., Mobley W.C. NGF effects on developing forebrain cholinergic neurons are regionally specific. Neurochem Res 1987, 12:985-994.
58. Yuen E.C., Howe C.L., Li Y., Holtzman D.M., Mobley W.C. Nerve growth factor and the neurotrophic factor hypothesis. Brain Dev 1996, 18:362-368.
59. Roux J.C., Dura E., Moncla A., Mancini J., Villard L. Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Eur J Neurosci 2007, 25:1915-1922.
60. Johansson J., Formaggio E., Fumagalli G., Chiamulera C. Choline up-regulates BDNF and down-regulates TrkB neurotrophin receptor in rat cortical cell culture. Neuroreport 2009, 20:828-832.
61. Zhang X., Liu C., Miao H., Gong Z.H., Nordberg A. Postnatal changes of nicotinic acetylcholine receptor alpha 2, alpha 3, alpha 4, alpha 7 and beta 2 subunits genes expression in rat brain. Int J Dev Neurosci 1998, 16:507-518.
62. Tribollet E., Bertrand D., Marguerat A., Raggenbass M. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience 2004, 124:405-420.
63. Glenn M.J., Kirby E.D., Gibson E.M., Wong-Goodrich S.J., Mellott T.J., Blusztajn J.K., et al. Age-related declines in exploratory behavior and markers of hippocampal plasticity are attenuated by prenatal choline supplementation in rats. Brain Res 2008, 1237:110-123.
64. Wong-Goodrich S.J., Glenn M.J., Mellott T.J., Blusztajn J.K., Meck W.H., Williams C.L. Spatial memory and hippocampal plasticity are differentially sensitive to the availability of choline in adulthood as a function of choline supply in utero. Brain Res 2008, 1237:153-166.
65. Kovacheva V.P., Mellott T.J., Davison J.M., Wagner N., Lopez-Coviella I., Schnitzler A.C., et al. Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of Dnmt1 expression. J Biol Chem 2007, 282:31777-31788.
66. Mobley W.C., Rutkowski J.L., Tennekoon G.I., Gemski J., Buchanan K., Johnston M.V. Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Brain Res 1986, 387:53-62.
67. Gu Z., Yu J., Perez-Polo J.R. Long term changes in brain cholinergic markers and nerve growth factor levels after partial immunolesion. Brain Res 1998, 801:190-197.
68. Gu Z., Yu J., Perez-Polo J.R. Responses in the aged rat brain after total immunolesion. J Neurosci Res 1998, 54:7-16.
69. Schaevitz L.R., Moriuchi J.M., Nag N., Mellot T.J., Berger-Sweeney J. Cognitive and social functions and growth factors in a mouse model of Rett syndrome. Physiol Behav 2010, 100:255-263.
70. Moretti P., Levenson J.M., Battaglia F., Atkinson R., Antalffy B., Amstrong D., et al. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci 2006, 26:319-327.
71. Hite K.C., Adams V.H., Hansen J.C. Recent advances in MeCP2 structure and function. Biochem Cell Biol 2009, 87:219-227.
72. Nag N., Moriuchi J.M., Peitzman C.G., Ward B.C., Kolodny N.H., Berger-Sweeney J.E. Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp2 1lox mice. Behav Brain Res 2009, 196:44-48.
73. Lonetti G., Angelucci A., Morando L., Boggio E.M., Giustetto M., Pizzorusso T. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol Psychiatry 2010, 67:657-665.